| CHD subtype | Single anomaly | Multi-anomalies | Subtotal | Subtype in major / minor anomaly | Subtype in all CHDs identified |
---|---|---|---|---|---|---|
Major | Subtotal | 6,947 | 2,831 | 9,778 | 100.00% | 53.81% |
1 | TOF | 2,034 | 350 | 2,384 | 24·38% | 13·12% |
2 | AVSD | 1,444 | 344 | 1,788 | 18·29% | 9·84% |
3 | DORV | 491 | 757 | 1,248 | 12·76% | 6·87% |
4 | TGA | 636 | 301 | 937 | 9·58% | 5·16% |
5 | SV | 282 | 501 | 783 | 8·01% | 4·31% |
6 | HLHS | 587 | 106 | 693 | 7·09% | 3·81% |
7 | PTA | 415 | 250 | 665 | 6·80% | 3·66% |
8 | HRHS | 451 | 64 | 515 | 5·27% | 2·83% |
9 | HS | 443 | 0 | 443 | 4·53% | 2·44% |
10 | PA | 75 | 63 | 138 | 1·41% | 0·76% |
11 | TAPVD | 47 | 33 | 80 | 0·82% | 0·44% |
12 | DOLV | 6 | 26 | 32 | 0·33% | 0·18% |
13 | AA | 5 | 21 | 26 | 0·27% | 0·14% |
14 | APW | 9 | 14 | 23 | 0·24% | 0·13% |
15 | EC | 22 | 1 | 23 | 0·24% | 0·13% |
Minor | Subtotal | 7,149 | 1,244 | 8,393 | 100·00% | 46·19% |
1 | VSD | 4,100 | 245 | 4,345 | 51·77% | 23·91% |
2 | PLSVC | 1,037 | 1 | 1,038 | 12·37% | 5·71% |
3 | COA/IAA | 227 | 439 | 666 | 7·94% | 3·67% |
4 | AS | 131 | 335 | 466 | 5·55% | 2·56% |
5 | PS | 422 | 22 | 444 | 5·29% | 2·44% |
6 | CVR | 378 | 6 | 384 | 4·58% | 2·11% |
7 | Rhabdomyoma | 283 | 14 | 297 | 3·54% | 1·63% |
8 | RAA | 231 | 13 | 244 | 2·91% | 1·34% |
9 | TVS | 140 | 65 | 205 | 2·44% | 1·13% |
10 | EA | 70 | 56 | 126 | 1·50% | 0·69% |
11 | TA | 23 | 17 | 40 | 0·48% | 0·22% |
12 | MVS | 25 | 8 | 33 | 0·39% | 0·18% |
13 | CAF | 15 | 8 | 23 | 0·27% | 0·13% |
14 | CTOH | 17 | 0 | 17 | 0·20% | 0·09% |
15 | MA | 9 | 6 | 15 | 0·18% | 0·08% |
16 | CT | 11 | 2 | 13 | 0·15% | 0·07% |
17 | VA | 9 | 1 | 10 | 0·12% | 0·06% |
18 | EFE | 6 | 5 | 11 | 0·13% | 0·06% |
19 | PCDA | 7 | 1 | 8 | 0·10% | 0·04% |
20 | BAV | 4 | 0 | 4 | 0·05% | 0·02% |
21 | CD | 4 | 0 | 4 | 0·05% | 0·02% |
 | Total | 14,096 | 4,075 | 18,171 |  |  |
 | Percentage | 76·24% | 23·76% |  |  |  |